AADI

Aadi Bioscience (AADI)

Aadi Bioscience Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AADI

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/09	05 : 05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AADI	Aadi Bioscience Inc
2024/05/08	21 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AADI	Aadi Bioscience Inc
2024/05/08	21 : 00	PR Newswire (US)	Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update	NASDAQ:AADI	Aadi Bioscience Inc
2024/05/01	21 : 01	PR Newswire (US)	Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update	NASDAQ:AADI	Aadi Bioscience Inc
2024/04/09	21 : 00	PR Newswire (US)	Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/17	21 : 00	PR Newswire (US)	Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/13	21 : 00	PR Newswire (US)	Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/06	22 : 00	PR Newswire (US)	Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/06	06 : 30	PR Newswire (US)	Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/05	09 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/05	09 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/05	09 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/02	06 : 08	PR Newswire (US)	Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa	NASDAQ:AADI	Aadi Bioscience Inc
2024/03/02	03 : 07	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/02/27	06 : 05	PR Newswire (US)	Aadi Bioscience to Present at the TD Cowen 44th Annual Healthcare Conference	NASDAQ:AADI	Aadi Bioscience Inc
2024/02/13	07 : 21	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:AADI	Aadi Bioscience Inc
2024/02/13	07 : 16	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:AADI	Aadi Bioscience Inc
2024/02/03	07 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2024/01/27	06 : 05	PR Newswire (US)	Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium	NASDAQ:AADI	Aadi Bioscience Inc
2024/01/20	06 : 05	PR Newswire (US)	Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium	NASDAQ:AADI	Aadi Bioscience Inc
2024/01/03	09 : 48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2023/12/15	07 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AADI	Aadi Bioscience Inc
2023/12/15	06 : 05	PR Newswire (US)	Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating Alterations	NASDAQ:AADI	Aadi Bioscience Inc
2023/12/08	06 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2023/12/06	08 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AADI	Aadi Bioscience Inc
2023/12/02	01 : 37	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AADI	Aadi Bioscience Inc
2023/11/09	06 : 54	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AADI	Aadi Bioscience Inc
2023/11/09	06 : 28	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:AADI	Aadi Bioscience Inc
2023/11/08	22 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AADI	Aadi Bioscience Inc
2023/11/08	22 : 00	PR Newswire (US)	Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate Update	NASDAQ:AADI	Aadi Bioscience Inc